Modern pharmaceutical engineering has enabled the development of peptides with extended half-lives, shifting administration from multiple daily injections to weekly protocols
There are several injectable peptide products pursuing similar indications with similar mechanisms of action from companies such as Altimmune, Viking, Jiangsu Hengrui, and Viking
Retatrutide is a first-in-class triple hormone receptor agonist whose Phase 3 data, released through late 2025 and 2026, has pushed Canadian research interest to record highs
Originally developed to treat Type 2 diabetes , this injectable medication has now emerged as a powerful tool for safe, sustained weight loss under the guidance of a healthcare professional
Why Ultrasonic Processing Is Central to Liposome Manufacturing Ultrasonic processing addresses several of the core challenges associated with liposome production
S-Acetyl L-Glutathione is an acetylated form of glutathione an important antioxidant in the human body